Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Revive Therapeutics Stock News

RVVTFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0227

0.000361.61%

At close: -

Revive Therapeutics (RVVTF) Forecast

News

Earnings Revive Therapeutics (RVVTF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Revive Therapeutics Stock News | OTC:RVVTF | Benzinga

Get the latest news on Revive Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Revive Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 31, 2024

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
Javier Hasse - Jul 31, 2024, 8:00AM

Wednesday, April 05, 2023

Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
Lara Goldstein - Apr 5, 2023, 9:57AM

Monday, April 03, 2023

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
Lara Goldstein - Apr 3, 2023, 3:46PM

Tuesday, March 28, 2023

Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
Lara Goldstein - Mar 28, 2023, 2:31PM

Monday, February 13, 2023

Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
Lara Goldstein - Feb 13, 2023, 4:01PM

Monday, February 06, 2023

MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
Lara Goldstein - Feb 6, 2023, 12:09PM

Friday, February 03, 2023

PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Lara Goldstein - Feb 3, 2023, 1:23PM

Tuesday, January 17, 2023

Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Lara Goldstein - Jan 17, 2023, 6:38PM

Thursday, January 12, 2023

Psychedelics Company Revive Raises $3.2M To Target Infectious Diseases, Disorders
Lara Goldstein - Jan 12, 2023, 1:11PM

Tuesday, December 20, 2022

Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Lara Goldstein - Dec 19, 2022, 8:23PM

Friday, December 16, 2022

Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
Lara Goldstein - Dec 16, 2022, 4:46PM

Thursday, December 01, 2022

Revive Therapeutics To Raise Up To $5M Via Private Placement
Vuk Zdinjak - Dec 1, 2022, 9:27AM

Wednesday, November 30, 2022

Psychedelic Stock Gainers And Losers From November 30, 2022
Benzinga Insights - Nov 30, 2022, 4:30PM

Tuesday, November 29, 2022

Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 29, 2022, 4:30PM

Monday, November 28, 2022

Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 28, 2022, 4:30PM

Friday, November 25, 2022

Psychedelic Stock Gainers And Losers From November 25, 2022
Benzinga Insights - Nov 25, 2022, 4:30PM

Thursday, November 24, 2022

Psychedelic Stock Gainers And Losers From November 24, 2022
Benzinga Insights - Nov 24, 2022, 4:30PM

Wednesday, November 23, 2022

Psychedelic Stock Gainers And Losers From November 23, 2022
Benzinga Insights - Nov 23, 2022, 4:30PM

Tuesday, November 22, 2022

Psychedelic Stock Gainers And Losers From November 22, 2022
Benzinga Insights - Nov 22, 2022, 4:30PM

Monday, November 21, 2022

Psychedelic Stock Gainers And Losers From November 21, 2022
Benzinga Insights - Nov 21, 2022, 4:30PM

Friday, November 18, 2022

Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 18, 2022, 4:30PM

Thursday, November 17, 2022

Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 17, 2022, 4:30PM

Wednesday, November 16, 2022

Psychedelic Stock Gainers And Losers From November 16, 2022
Benzinga Insights - Nov 16, 2022, 4:30PM

Tuesday, November 15, 2022

GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 15, 2022, 4:30PM

Thursday, November 10, 2022

Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 10, 2022, 4:34PM

Wednesday, November 09, 2022

Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 9, 2022, 3:41PM

Tuesday, November 08, 2022

Psychedelic Stock Gainers And Losers From November 8, 2022
Benzinga Insights - Nov 8, 2022, 3:34PM

Monday, November 07, 2022

Compass Pathways, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 7, 2022, 4:48PM

Thursday, November 03, 2022

Psychedelic Stock Gainers And Losers From November 3, 2022
Benzinga Insights - Nov 3, 2022, 4:53PM

Wednesday, November 02, 2022

Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights - Nov 2, 2022, 4:35PM

Thursday, October 27, 2022

Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 27, 2022, 4:33PM

Wednesday, October 26, 2022

Psychedelic Stock Gainers And Losers From October 26, 2022
Benzinga Insights - Oct 26, 2022, 4:31PM

Tuesday, October 25, 2022

Psychedelic Stock Gainers And Losers From October 25, 2022
Benzinga Insights - Oct 25, 2022, 4:48PM

Friday, October 21, 2022

Allied, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 21, 2022, 5:18PM

Tuesday, October 18, 2022

Psychedelic Stock Gainers And Losers From October 18, 2022
Benzinga Insights - Oct 18, 2022, 4:50PM

Monday, October 17, 2022

Psychedelic Stock Gainers And Losers From October 17, 2022
Benzinga Insights - Oct 17, 2022, 4:55PM

Friday, October 14, 2022

Small Pharma, Cybin Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 14, 2022, 4:43PM

Wednesday, October 12, 2022

Psychedelic Stock Gainers And Losers From October 12, 2022
Benzinga Insights - Oct 12, 2022, 6:01PM

Tuesday, October 11, 2022

Numinus Wellness, Small Pharma Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 11, 2022, 4:51PM

Monday, October 10, 2022

Psychedelic Stock Gainers And Losers From October 10, 2022
Benzinga Insights - Oct 10, 2022, 4:38PM

Thursday, October 06, 2022

Psychedelic Stock Gainers And Losers From October 6, 2022
Benzinga Insights - Oct 6, 2022, 4:32PM

Tuesday, October 04, 2022

Allied, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 4, 2022, 5:09PM

Monday, October 03, 2022

Cybin, GH Research Among Top Psychedelic Movers Of Today
Benzinga Insights - Oct 3, 2022, 4:31PM

Friday, September 30, 2022

Allied, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights - Sep 30, 2022, 4:31PM

Thursday, September 29, 2022

Allied, Compass Pathways Among Top Psychedelic Movers Of Today
Benzinga Insights - Sep 29, 2022, 4:55PM

Wednesday, September 28, 2022

Psychedelic Stock Gainers And Losers From September 28, 2022
Benzinga Insights - Sep 28, 2022, 4:58PM

Tuesday, September 27, 2022

Biomind Labs, Allied Among Top Psychedelic Movers Of Today
Benzinga Insights - Sep 27, 2022, 4:41PM

Monday, September 26, 2022

Small Pharma, Revive Therapeutics Among Top Psychedelic Movers Of Today
Benzinga Insights - Sep 26, 2022, 4:32PM

Friday, September 23, 2022

Will Cannabis Entrepreneurs Switch To Psychedelics?
Andrew Ward - Sep 23, 2022, 10:47AM

Thursday, September 22, 2022

Psychedelic Stock Gainers And Losers From September 22, 2022
Benzinga Insights - Sep 22, 2022, 4:33PM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved